Patent · US Active

Non-nucleotide compositions and method for treating pain

US7749980B2 · kind B2 · utility

19Cited by
7References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 21, 2004
Grant dateJul 6, 2010
Priority date
Expiry dateOct 18, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P29/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to a method of treating pain. The method comprises administering to a subject a pharmaceutical composition comprising an effective amount of a P2X receptor antagonist. The methods of the present invention are useful in reducing pain, such as traumatic pain, neuropathic pain, organ pain and/or pain associated with diseases. The P2X receptor antagonists useful for this invention are non-nucleotide compounds of general Formula I. Compounds of Formula I can be used alone to treat pain. Compounds of Formula I can also be used in conjunction with other therapeutic agents or adjunctive therapies commonly used to treat pain, thus enhancing the therapeutic effect of pain reduction.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.